Benjamin Graham fit · Defensive deep-value investing
Is Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) a Benjamin Graham Stock?
Meets 4/7 Graham criteria - classic deep-value candidate.
88/100
ALikely Graham stock
4/7 criteria passed
+10 sector-quality lift. Top-quintile within its sector on 5 of 5 quality metrics. Raw pillar score 78 → lifted to 88 before grade derivation.
Benjamin Graham's Criteria, Applied to SUNPHARMA.NS
P/E ≤ 15
key37.6x
P/B ≤ 1.5
key5.2x
Current ratio ≥ 2
2.8x
Debt / Equity ≤ 1
0.1x
5y profitable
keyYes
Earnings yield ≥ 7%
2.7%
Revenue growing
10.4%
How SUNPHARMA.NS Scores on Other Strategies
Live Financial Snapshot
Market cap
$4.33T
P/E (TTM)
37.6x
ROIC (TTM)
13.14%
Gross margin
80.17%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is SUNPHARMA.NS's Benjamin Graham fit score?
SUNPHARMA.NS scores 88/100 on our Benjamin Graham fit engine - grade A. Meets 4/7 Graham criteria - classic deep-value candidate.
Does Benjamin Graham actually own SUNPHARMA.NS?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends SUNPHARMA.NS.
How often is this score updated?
SUNPHARMA.NS's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends SUNPHARMA.NS.